Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis

被引：0
|
作者：
Leonardi, C
Goffe, B
Sobell, J
Caro, I
Wang, X
Papp, K
机构：
[1] Cent Dermatol Inc, St Louis, MO USA
[2] Minor & James Med Clin, Seattle, WA USA
[3] ORA Clin Res, N Andover, MA USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2004年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
347
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [1] Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis
    Papp, KA
    Miller, B
    Gordon, KB
    Caro, I
    Kwon, P
    Compton, PG
    Leonardi, CL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : S164 - S170
  • [2] Safety and tolerability of extended efalizumab therapy in patients with chronic moderate to severe plaque psoriasis
    Gottlieb, A
    Hamilton, T
    Rafal, E
    Caro, I
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB11 - AB11
  • [3] Safety and efficacy of efalizumab therapy for elderly patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A
    Lizzul, P
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P194 - P194
  • [4] The safety of efalizumab in patients with moderate to severe plaque psoriasis: Summary of clinical trial experience
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P157 - P157
  • [5] Efalizumab for the treatment of moderate to severe plaque psoriasis
    Jordan, JK
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1476 - 1482
  • [6] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: Review of clinical data. Part II
    Papp, Kim A.
    Camisa, Charles
    Stone, Stephen P.
    Caro, Ivor
    Wang, Xiaolin
    Compton, Peter
    Walicke, Patricia A.
    Gottlieb, Alice B.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2005, 9 (06) : 313 - 323
  • [7] Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial
    Gordon, KB
    Papp, KA
    Hamilton, TK
    Walicke, PA
    Dummer, W
    Li, N
    Bresnahan, BW
    Menter, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3073 - 3080
  • [8] Efficacy and safety outcomes of long-term efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: an update
    Gottlieb, AB
    Hamilton, T
    Caro, I
    Gordon, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A57 - A57
  • [9] Safety events in moderate to severe psoriasis patients treated with efalizumab
    Ehrlich, Alison
    Caro, Ivor
    Werther, Winifred
    Chen, Yun
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [10] Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial
    Papp, KA
    Bressinck, R
    Fretzin, S
    Goffe, B
    Kempers, S
    Gordon, KB
    Caro, I
    Walicke, PA
    Wang, XL
    Menter, A
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (05) : 605 - 614
12345